Informing iQOS Regulations in the United States: A Synthesis of What We Know

Carla J. Berg, Yael Bar-Zeev, Hagai Levine

Research output: Contribution to journalArticlepeer-review

Abstract

The tobacco industry offers various products, including heated tobacco products (HTPs). Philip Morris International’s (PMI) “iQOS” has the greatest HTP market share, as well as research on its use and impact. iQOS was released in 2014 and is now in more than 40 countries. The U.S. Food and Drug Administration announced permission for PMI to sell iQOS in the United States in April 2019, and iQOS was launched in October 2019. Decisions pending its modified risk tobacco product (MRTP) application will occur subsequently. The U.S. regulatory efforts regarding iQOS could be informed by examining (a) Philip Morris USA other product marketing efforts and (b) the iQOS market in countries where it is available. This article briefly addresses these two points with extant literature and suggests that future research should address important gaps in what is currently known, including strategic international collaborations and research, which historically has been critical for advancing tobacco control globally.

Original languageAmerican English
JournalSAGE Open
Volume10
Issue number1
DOIs
StatePublished - Jan 2020

Keywords

  • alternative tobacco products
  • marketing
  • tobacco control
  • tobacco industry

All Science Journal Classification (ASJC) codes

  • General Arts and Humanities
  • General Social Sciences

Fingerprint

Dive into the research topics of 'Informing iQOS Regulations in the United States: A Synthesis of What We Know'. Together they form a unique fingerprint.

Cite this